We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Published in Neurology

Journal Scan / Research · January 05, 2021

Association of Caffeine and Related Analytes With Resistance to Parkinson Disease in LRRK2 Mutation Carriers

Neurology

 

Save Recommend
Share

Additional Info

Neurology
Association of Caffeine and Related Analytes With Resistance to Parkinson Disease Among LRRK2 Mutation Carriers: A Metabolomic Study
Neurology 2020 Dec 15;95(24)e3428-e3437, GF Crotty, R Maciuca, EA Macklin, J Wang, M Montalban, SS Davis, JI Alkabsh, R Bakshi, X Chen, A Ascherio, G Astarita, S Huntwork-Rodriguez, MA Schwarzschild

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated